SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-084548
Filing Date
2020-07-17
Accepted
2020-07-17 17:00:18
Documents
12
Period of Report
2020-07-16
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2025080-1_8k.htm   iXBRL 8-K 29242
  Complete submission text file 0001104659-20-084548.txt   204206

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA icpt-20200716.xsd EX-101.SCH 3207
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE icpt-20200716_lab.xml EX-101.LAB 34591
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE icpt-20200716_pre.xml EX-101.PRE 22724
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2025080-1_8k_htm.xml XML 3615
Mailing Address 10 HUDSON YARDS, 37TH FLOOR New York NY 10001
Business Address 10 HUDSON YARDS, 37TH FLOOR NEW YORK NY 10001 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Filer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35668 | Film No.: 201034253
SIC: 2834 Pharmaceutical Preparations